NCT01691872View on ClinicalTrials.gov

Pharmacokinetic Study of Retigabine Extended Release (XR) Formulation in Healthy Adult Japanese and Caucasian Subjects

PHASE1WithdrawnINTERVENTIONAL

0

Timeline

Start Date

October 10, 2012

Primary Completion Date

October 18, 2012

Study Completion Date

October 18, 2012

Conditions

Epilepsy, Partial

Interventions

DRUG

Retigabine

Retigabine

Trial Locations (1)

890-0081

GSK Investigational Site, Kagoshima

Sponsors

Lead Sponsor

GlaxoSmithKline

All Listed Sponsors

lead

GlaxoSmithKline

INDUSTRY